SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is highly trending amid its intensifying bid to acquire Warner Bros. Discovery, recently enhancing its all-cash offer with a significant personal equity financing guarantee to address concerns. This move is sparking widespread community debate over whether Paramount Skydance's revised proposal or Netflix's competing offer provides the superior strategic fit and long-term value for Warner Bros. Discovery shareholders.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is surging following the highly anticipated FDA approval of Yartemlea, its first-in-class therapy for transplant-associated thrombotic microangiopathy (TA-TMA), marking a significant milestone after years of development. The community is actively celebrating this breakthrough, recognizing the drug's potential as the sole approved treatment for a life-threatening condition and discussing its substantial upside given the company's strong financial position and potential for analyst upgrades and future partnerships.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending amid recent contract awards, highlighted by a substantial notice to proceed for a major AI data center power project, positioning the company as a key player in the energy sector's evolution. The community is keenly focused on its potential to address the surging electricity demands for AI, viewing the firm as a crucial 'picks and shovels' enabler for this booming industry.

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.

Palatin Technologies Inc.

Palatin Technologies is highly active on the feeds after receiving a NYSE American delisting notice, which the company is appealing while concurrently pursuing new financing. This is juxtaposed against recent positive clinical data in dry eye disease and obesity, including a program showing potential for sustained weight maintenance following GLP-1 therapy cessation. The community remains sharply divided, with bulls highlighting the undervalued pipeline and partnership potential, while bears express deep frustration over management's perceived past financial mismanagement and dilution concerns.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending following multiple analyst upgrades and a raised profit outlook for the coming year, underscoring confidence in its integrated healthcare model. The community is actively discussing its strategic initiatives, including recent acquisitions and advancements in healthcare benefits, against broader sector challenges impacting Medicare Advantage plans. Investors are weighing its current valuation while often viewing it as a defensive play offering stability and a dividend.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is garnering significant attention as market participants consider its strategic positioning to benefit from the Biosecure Act and Project Genesis, which prioritize domestic biotech infrastructure. Community discussion highlights optimism around its AI and synthetic biology platform, recent partnerships, and institutional accumulation, with many debating its potential for a "rebirth" in a landscape shifting away from foreign supply chains.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a polarized debate regarding the impact of new GLP-1 medications and proposed legislation on its core business, while simultaneously expanding its weight-loss program internationally. Despite high institutional ownership and significant short interest fueling talks of a potential squeeze, the community remains divided between those seeing a long-term opportunity and others frustrated by recent stock performance.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently a major talking point following its strategic move to Nasdaq, aiming to redefine itself as a tech-enabled e-commerce leader rather than just a traditional retailer. The community is actively debating its sustained rally driven by strong holiday sales, rapid digital growth, and significant investments in AI and faster fulfillment, while some question its elevated valuation relative to other tech giants.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is gaining significant attention as its upcoming "Fusaka" upgrade is anticipated to boost scalability, driving expectations for increased institutional adoption. Amid bullish analyst forecasts, the community is actively discussing ETH's role as a foundational asset for tokenized funds, positioning it for a potential major price breakout despite recent market volatility.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery (WBD) is trending as the acquisition battle intensifies following Paramount Skydance's (PSKY) amended all-cash bid, now backed by a substantial personal financing guarantee from Oracle founder Larry Ellison. The community is actively debating if this strengthens PSKY's position against Netflix's (NFLX) competing offer, with many anticipating a heightened bidding war and further revisions to secure WBD's valuable content assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Calumet (NASDAQ:CLMT) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

Calumet (NASDAQ:CLMT) Shares Cross Above 200 Day Moving Average - Here's What Happened...

Wall Street Zen Downgrades Calumet (NASDAQ:CLMT) to Hold

Wall Street Zen downgraded shares of Calumet from a "buy" rating to a "hold" rating in a report on Sunday...

102,160 Shares in Calumet, Inc. $CLMT Purchased by Rhumbline Advisers

Rhumbline Advisers bought a new stake in shares of Calumet, Inc. (NASDAQ:CLMT - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and...

Calumet to Attend Wells Fargo Annual Energy & Power Symposium

Calumet to Attend Wells Fargo Annual Energy & Power Symposium Calumet to Attend Wells Fargo Annual Energy & Power Symposium PR Newswire INDIANAPOLIS, Dec. 8, 2025 INDIANAPOLIS, Dec. 8, 2025...

Calumet (NASDAQ:CLMT) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded Calumet from a "hold" rating to a "buy" rating in a research report on Saturday...

Calumet, Inc. $CLMT Stock Holdings Lifted by Two Seas Capital LP

Two Seas Capital LP boosted its position in shares of Calumet, Inc. (NASDAQ:CLMT - Free Report) by 56.9% in the second quarter, according to its most recent filing with the Securities & Exchange...

Diametric Capital LP Makes New Investment in Calumet, Inc. $CLMT

Diametric Capital LP bought a new stake in Calumet, Inc. (NASDAQ:CLMT - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The...

Calumet, Inc. (NASDAQ:CLMT) Given Consensus Recommendation of "Hold" by Analysts

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) has received an average recommendation of "Hold" from the eight analysts that are currently covering the company, Marketbeat.com reports. One analyst has...

Intech Investment Management LLC Purchases New Shares in Calumet, Inc. $CLMT

Intech Investment Management LLC purchased a new position in shares of Calumet, Inc. (NASDAQ:CLMT - Free Report) in the second quarter, according to the company in its most recent filing with the...

Calumet (NASDAQ:CLMT) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen upgraded Calumet from a "sell" rating to a "hold" rating in a research note on Sunday...

Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general and administrative expenses not allocated to other segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.

CLMT
Calumet Specialty Products Partners LP

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLMT News

CLMTCalumet Specialty Products Partners LP